Literature DB >> 16293702

Protocol for measurement of liver fat by computed tomography.

Lance E Davidson1, Jennifer L Kuk, Timothy S Church, Robert Ross.   

Abstract

To develop a protocol for measurement of liver fat using computed tomography (CT), we conducted a preliminary study with 118 men and 76 women to determine a readily identifiable vertebral landmark at which the CT image displayed both liver and spleen. Analysis of five landmarks revealed that the CT image obtained at the T12-L1 level simultaneously displayed the liver and spleen in 90% of the men and women. The T12-L1 protocol was cross-validated on a sample of 130 men and 113 women. In this sample, we also assessed the regional characteristics of liver and spleen tissue attenuation at the T12-L1 level by subdividing each image into quartiles from anterior to posterior, each of which were further divided into medial and lateral regions. A similar analysis was performed on images located 12 mm above and below T12-L1. The T12-L1 image displayed both liver and spleen in 92% (403 of 437) of the combined study sample. There was a significant (P<0.005) stepwise increase in attenuation values [Hounsfield units (HU)] from the inferior to superior image. Although some significant (P<0.05) differences were observed between the eight regions by comparison to the whole liver or spleen, the average magnitude of the difference was <2.0 HU for liver and <3.5 HU for spleen. Acquisition of a single CT image at the T12-L1 level is a practical and reliable method for routine measurement of liver fat in research and clinical settings.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16293702     DOI: 10.1152/japplphysiol.00986.2005

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  30 in total

1.  Effects of intensive insulin therapy alone and in combination with pioglitazone on body weight, composition, distribution and liver fat content in patients with type 2 diabetes.

Authors:  P K Shah; S Mudaliar; A R Chang; V Aroda; M Andre; P Burke; R R Henry
Journal:  Diabetes Obes Metab       Date:  2011-06       Impact factor: 6.577

2.  Association of PNPLA3 with non-alcoholic fatty liver disease in a minority cohort: the Insulin Resistance Atherosclerosis Family Study.

Authors:  Lynne E Wagenknecht; Nicholette D Palmer; Donald W Bowden; Jerome I Rotter; Jill M Norris; Julie Ziegler; Yii-Der I Chen; Steven Haffner; Ann Scherzinger; Carl D Langefeld
Journal:  Liver Int       Date:  2011-01-13       Impact factor: 5.828

3.  Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: the Coronary Artery Risk Development in Young Adults Study.

Authors:  Lisa B VanWagner; Hongyan Ning; Cora E Lewis; Christina M Shay; John Wilkins; J Jeffrey Carr; James G Terry; Donald M Lloyd-Jones; David R Jacobs; Mercedes R Carnethon
Journal:  Atherosclerosis       Date:  2014-06-10       Impact factor: 5.162

4.  Fatty liver, abdominal visceral fat, and cardiometabolic risk factors: the Jackson Heart Study.

Authors:  Jiankang Liu; Caroline S Fox; DeMarc Hickson; Aurelian Bidulescu; J Jeffery Carr; Herman A Taylor
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

5.  Characterization of mesothelioma and tissues present in contrast-enhanced thoracic CT scans.

Authors:  Neal Corson; William F Sensakovic; Christopher Straus; Adam Starkey; Samuel G Armato
Journal:  Med Phys       Date:  2011-02       Impact factor: 4.071

6.  Automated measurement of liver attenuation to identify moderate-to-severe hepatic steatosis from chest CT scans.

Authors:  Artit Jirapatnakul; Anthony P Reeves; Sara Lewis; Xiangmeng Chen; Teng Ma; Rowena Yip; Xing Chin; Shuang Liu; Ponni V Perumalswami; David F Yankelevitz; Michael Crane; Andrea D Branch; Claudia I Henschke
Journal:  Eur J Radiol       Date:  2019-10-25       Impact factor: 3.528

7.  Non-invasive Diagnosis of Fibrosis in Non-alcoholic Fatty Liver Disease.

Authors:  Anil Arora; Praveen Sharma
Journal:  J Clin Exp Hepatol       Date:  2012-07-21

8.  Liver fat is reproducibly measured using computed tomography in the Framingham Heart Study.

Authors:  Elizabeth K Speliotes; Joseph M Massaro; Udo Hoffmann; Meredith C Foster; Dushyant V Sahani; Joel N Hirschhorn; Christopher J O'Donnell; Caroline S Fox
Journal:  J Gastroenterol Hepatol       Date:  2008-06       Impact factor: 4.029

9.  Changes in regional adiposity and cardio-metabolic function following a weight loss program with sibutramine in obese men with obstructive sleep apnea.

Authors:  Craig L Phillips; Brendon J Yee; Mike I Trenell; John S Magnussen; David Wang; Dev Banerjee; Norbert Berend; Ronald R Grunstein
Journal:  J Clin Sleep Med       Date:  2009-10-15       Impact factor: 4.062

10.  Fatty liver, abdominal adipose tissue and atherosclerotic calcification in African Americans: the Jackson Heart Study.

Authors:  Jiankang Liu; Solomon K Musani; Aurelian Bidulescu; J Jeffery Carr; James G Wilson; Herman A Taylor; Caroline S Fox
Journal:  Atherosclerosis       Date:  2012-08-10       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.